PACS Group, Inc. (NYSE:PACS – Get Free Report) was the target of unusually large options trading on Thursday. Investors purchased 9,053 call options on the stock. This represents an increase of 1,166% compared to the average daily volume of 715 call options.
PACS Group Stock Down 8.5%
NYSE PACS traded down $3.94 during trading on Thursday, hitting $42.35. 270,286 shares of the company traded hands, compared to its average volume of 887,929. PACS Group has a 12 month low of $24.56 and a 12 month high of $51.68. The business has a fifty day simple moving average of $45.51 and a 200 day simple moving average of $40.58. The company has a market capitalization of $6.72 billion, a P/E ratio of 23.93, a PEG ratio of 1.58 and a beta of -0.14. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.22.
PACS Group (NYSE:PACS – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. As a group, sell-side analysts predict that PACS Group will post 2.05 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the company. Weiss Ratings raised PACS Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, November 4th. Truist Financial reaffirmed a “buy” rating and set a $65.00 price objective (up from $62.00) on shares of PACS Group in a research report on Thursday, November 5th. UBS Group lifted their target price on shares of PACS Group from $60.00 to $67.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Royal Bank Of Canada boosted their target price on shares of PACS Group from $57.00 to $64.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, JPMorgan Chase & Co. increased their price target on shares of PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Seven research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, PACS Group currently has a consensus rating of “Moderate Buy” and an average target price of $62.50.
Check Out Our Latest Stock Report on PACS Group
Insider Transactions at PACS Group
In related news, COO Joshua Jergensen sold 40,000 shares of PACS Group stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $50.11, for a total transaction of $2,004,400.00. Following the completion of the sale, the chief operating officer owned 2,416,320 shares of the company’s stock, valued at approximately $121,081,795.20. This trade represents a 1.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 19,235 shares of the business’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $50.64, for a total value of $974,060.40. Following the completion of the transaction, the chief executive officer owned 53,934,866 shares in the company, valued at $2,731,261,614.24. This trade represents a 0.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,454,244 shares of company stock worth $67,394,064 in the last ninety days. Company insiders own 70.10% of the company’s stock.
Institutional Investors Weigh In On PACS Group
Several institutional investors and hedge funds have recently added to or reduced their stakes in PACS. Zacks Investment Management boosted its position in PACS Group by 11.3% during the third quarter. Zacks Investment Management now owns 40,754 shares of the company’s stock worth $1,693,000 after purchasing an additional 4,123 shares during the period. Aquatic Capital Management LLC bought a new position in shares of PACS Group in the third quarter valued at approximately $723,000. Cetera Investment Advisers raised its position in shares of PACS Group by 57.1% in the third quarter. Cetera Investment Advisers now owns 18,201 shares of the company’s stock valued at $756,000 after purchasing an additional 6,619 shares during the period. Caxton Associates LLP bought a new position in shares of PACS Group in the third quarter valued at approximately $289,000. Finally, Bleakley Financial Group LLC lifted its stake in shares of PACS Group by 46.7% in the third quarter. Bleakley Financial Group LLC now owns 32,604 shares of the company’s stock worth $1,355,000 after buying an additional 10,385 shares during the last quarter.
About PACS Group
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Further Reading
- Five stocks we like better than PACS Group
- The Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027
- Lowe’s Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the Math
- Grounded at 52-Week Lows: When Will Boeing Stock Take Flight?
- Apple’s Next Margin Defense Could Be Hiding in Your Wallet
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
